These data therefore suggest that B32B3 is specifically targeting VprBP kinase activity and that the observed suppression of cancer cell growth is generated from B32B3 effects on VprBP‐mediated H2AT120p and downstream gene silencing pathway. Here, DCAF1 is linked to cancer.